Hypoglycemia as a barrier to glycemic control (Q35690608)

9 August 2017

1 reference

title

Hypoglycemia as a barrier to glycemic control (English)

1 reference

9 August 2017

1 reference

Stephen Davis

1

1 reference

PubMed ID

15019602

9 August 2017

Miriam D Alonso

series ordinal

2

1 reference

9 August 2017

1 January 2004

1 reference

Journal of Diabetes and its Complications

9 August 2017

1 reference

9 August 2017

18

1 reference

9 August 2017

60-68

1 reference

9 August 2017

1

1 reference

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Frequency of severe hypoglycemia in patients with non-insulin-dependent diabetes mellitus treated with sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Drug-induced hypoglycemic coma in 102 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Insulin analogs with improved pharmacokinetic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

1 reference

7 January 2021

A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Symptoms of Acute Insulin-Induced Hypoglycemia in Humans With and Without IDDM: Factor-Analysis Approach

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

1 reference

7 January 2021

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Reproducibility of glucose measurements using the glucose sensor.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Detection of hypoglycemia with the GlucoWatch biographer

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Intensified conventional insulin treatment and neuropsychological impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Hypoglycemia-associated autonomic failure in advanced type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900058-8

7 January 2021

10.1016/S1056-8727(03)00058-8

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15019602